Clinicians should consider these findings when using atypical antipsychotics in patients at risk for pneumonia.
All articles by Laura Stiles
Researchers assessed pooled randomized clinical trial data (NAVIGATE I and II; N5641) to examine the change in SF-36v2 and SF-6D from baseline to the end of double blind and to the end of the studies.
By
Publish Date
Prior to this expanded indication, patients with this challenging, rare disease did not have an FDA-approved treatment option.
By
Publish Date
Pulmonary arterial hypertension is becoming a major cause of death in patients with systemic sclerosis.
By
Publish Date
-
Latest News Your top articles for Friday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses